NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

0.6800 +0.0100 (+1.49%)
As of 12:23 PM EDT. Market Open.
Loading Chart for CLOV
DELL
  • Previous Close 0.6700
  • Open 0.6800
  • Bid 0.6533 x 900
  • Ask 0.6836 x 100
  • Day's Range 0.6620 - 0.7000
  • 52 Week Range 0.6060 - 1.6300
  • Volume 1,419,588
  • Avg. Volume 9,409,193
  • Market Cap (intraday) 336.799M
  • Beta (5Y Monthly) 1.85
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4400
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.44

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

Performance Overview: CLOV

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV
28.57%
S&P 500
7.00%

1-Year Return

CLOV
7.10%
S&P 500
25.35%

3-Year Return

CLOV
92.25%
S&P 500
22.09%

5-Year Return

CLOV
--
S&P 500
67.81%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    331.85M

  • Enterprise Value

    93.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    1.16

  • Enterprise Value/Revenue

    0.05

  • Enterprise Value/EBITDA

    -0.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.48%

  • Return on Assets (ttm)

    -16.98%

  • Return on Equity (ttm)

    -66.33%

  • Revenue (ttm)

    2.04B

  • Net Income Avi to Common (ttm)

    -213.36M

  • Diluted EPS (ttm)

    -0.4400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    242.68M

  • Total Debt/Equity (mrq)

    1.63%

  • Levered Free Cash Flow (ttm)

    71.6M

Research Analysis: CLOV

Analyst Price Targets

1.00
1.44 Average
0.6800 Current
2.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CLOV

Fair Value

0.6800 Current
 

Dividend Score

0 Low
CLOV
Sector Avg.
100 High
 

Hiring Score

0 Low
CLOV
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CLOV
Sector Avg.
100 High
 

People Also Watch